2016
DOI: 10.1016/j.addr.2016.03.002
|View full text |Cite
|
Sign up to set email alerts
|

Bioengineered protein-based nanocage for drug delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
154
0
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 191 publications
(156 citation statements)
references
References 238 publications
1
154
0
1
Order By: Relevance
“…DOX loading via non-covalent or covalent attachments on various icosahedral (sphere-like) VNPs has been reported (reviewed in 52 ). For example, DOX has been covalently attached to 30 nm-sized CPMV (up to 270 DOX per VNP) or Qβ bacteriophage (up to 500 DOX per VNP).…”
Section: Discussionmentioning
confidence: 99%
“…DOX loading via non-covalent or covalent attachments on various icosahedral (sphere-like) VNPs has been reported (reviewed in 52 ). For example, DOX has been covalently attached to 30 nm-sized CPMV (up to 270 DOX per VNP) or Qβ bacteriophage (up to 500 DOX per VNP).…”
Section: Discussionmentioning
confidence: 99%
“…Natural structure-based nanocages (such as the ferritins, small heat shock proteins, and vaults) and most of the viruses (virus-like particles, cowpea chlorotic mottle virus, cowpea mosaic virus, bacteriophage, and drug loadings in protein-based nanocages) are all important examples. 103 A safe and smart pH-sensitive nanocompound drug delivery with high drug delivery ability was prepared by conjugating DOX to xyloglucan (XG) using acid-cleavable hydrazone bonds and, then, encapsulating DOX by the self-assembly of XG-DOX conjugates to increase drug delivery into the tumor cells. 104 The toxicity effects, such as the risk of bleeding due to heparin's anticoagulant activity, decreased using a novel combination nanosystem of low molecular weight heparin and ursolic acid (UA), which is also an angiogenesis inhibitor for tumor treatment.…”
mentioning
confidence: 99%
“…Hollow particles with sizes in the nanometer range (nanocages) have found widespread application in the medical field. For instance, the encapsulation of pharmaceutical drugs inside nanocages has tremendously increased the control over drug delivery on the molecular level . By modifying the exterior of the particles, targeting towards a desired tissue can be achieved, which reduces the side effects of the drug.…”
Section: Introductionmentioning
confidence: 99%
“…For instance, the encapsulation of pharmaceutical drugs inside nanocages has tremendously increased the control over drug delivery on the molecular level. [1,2] By modifying the exterior of the particles, targeting towards ad esired tissue can be achieved, which reduces the side effects of the drug.A tt he same time, the nanocage enhances the stabilityo ft he drug and increasesits half-life in vivo by shieldingi tf rom interfering external influences. The success of these types of designsisi llustrated by liposomal drug-delivery systems thata re now on the market or in clinical trials.…”
Section: Introductionmentioning
confidence: 99%